Literature DB >> 2298052

Performance evaluation of contemporary spirometers.

S B Nelson1, R M Gardner, R O Crapo, R L Jensen.   

Abstract

A comprehensive evaluation of 62 spirometers from 37 different sources was performed using a two-part protocol: calibrated syringe, and dynamic waveform testing. All testing was done with ambient air. Calibrated syringe testing examined the ability of the spirometers to accurately measure the output of a 3 L calibrating syringe under varying conditions. The accuracy, FVC volume linearity, and stability of each spirometer was determined from these data. All but five of 42 spirometers accurately measured a 3 L calibrating syringe to within +/- 3 percent. Dynamic waveform testing consisted of introducing 24 standard waveforms into the spirometer from a computer-controlled air pump. The values of FVC, FEV1, and FEF25-75% were compared to the actual values for each waveform to determine a performance rating. Only 35 (56.5 percent) of the spirometers performed acceptably when measuring the 24 standard waveforms. Nine (14.5 percent) were marginal and 18 (29.0 percent) were unacceptable. Fifty-nine (95 percent) of the 62 spirometers were computerized. Software errors were found in 25 percent of the computerized systems evaluated. Although using a 3 L syringe for quality control purposes is essential, simple testing of spirometers with a 3 L calibrating syringe for validation purposes was inadequate to assess spirometer performance when compared to dynamic waveform testing. Dynamic waveform testing is essential to accurately measure and validate acceptability of spirometer system performance.

Mesh:

Year:  1990        PMID: 2298052     DOI: 10.1378/chest.97.2.288

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

1.  Dawning of a new lung age?

Authors:  Brendan Cooper
Journal:  Prim Care Respir J       Date:  2012-03

2.  The precision of longitudinal lung function measurements: monitoring and interpretation.

Authors:  E Hnizdo; L Yu; L Freyder; M Attfield; J Lefante; H W Glindmeyer
Journal:  Occup Environ Med       Date:  2005-10       Impact factor: 4.402

Review 3.  Automated metabolic gas analysis systems: a review.

Authors:  D J Macfarlane
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

4.  Respiratory impairment and mortality in older persons: a novel spirometric approach.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Gail McAvay; Henry Klar Yaggi; Peter H Van Ness; John Concato
Journal:  J Investig Med       Date:  2011-10       Impact factor: 2.895

5.  Assessment of a new transtelephonic portable spirometer.

Authors:  S Abboud; I Bruderman
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

6.  Lung function in healthy never smoking adults: reference values and lower limits of normal of a Swiss population.

Authors:  O Brändli; C Schindler; N Künzli; R Keller; A P Perruchoud
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

7.  Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.

Authors:  A Johannessen; E R Omenaas; P S Bakke; A Gulsvik
Journal:  Thorax       Date:  2005-08-05       Impact factor: 9.139

8.  Forced midexpiratory time: reference values and the effect of cigarette smoking.

Authors:  L K Brown; A Miller; M Pilipski; T S Lau
Journal:  Lung       Date:  1995       Impact factor: 2.584

9.  A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis genetic modifier studies.

Authors:  Chelsea Taylor; Clayton W Commander; Joseph M Collaco; Lisa J Strug; Weili Li; Fred A Wright; Aaron D Webel; Rhonda G Pace; Jaclyn R Stonebraker; Kathleen Naughton; Ruslan Dorfman; Andrew Sandford; Scott M Blackman; Yves Berthiaume; Peter Paré; Mitchell L Drumm; Julian Zielenski; Peter Durie; Garry R Cutting; Michael R Knowles; Mary Corey
Journal:  Pediatr Pulmonol       Date:  2011-04-01

10.  Single breath transfer factor for carbon monoxide in an asymptomatic population of never smokers.

Authors:  A Gulsvik; P Bakke; S Humerfelt; E Omenaas; T Tosteson; S T Weiss; F E Speizer
Journal:  Thorax       Date:  1992-03       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.